Trials / Completed
CompletedNCT06178536
Clinical and Radiographic Assessment of a Novel Wedge Shape Implant Placed in Edentulous Narrow Ridges
Clinical and Radiographic Assessment of a Novel Wedge Shape Implant Placed in Edentulous Narrow Ridges: Comparison of Bone Consuming and Bone Expanding Techniques for Implants Presenting Either Machined or Roughened Transcortical Portion
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Christian Makary · Academic / Other
- Sex
- All
- Age
- 35 Years – 62 Years
- Healthy volunteers
- Accepted
Summary
The aim is to clinically and radiographically assess a novel wedge implant placed in narrow ridges. * 60 wedge implants (Rex Implants, Columbus, OH, USA) will be placed using Piezosurgery® following either a bone consumption (n=30) or bone expansion technique (n=30). Each group (bone consumption and bone expansion) will be divided into 2 surface treatments: machined transcortical portion (n=15) and roughened transcortical portion (n=15). * Record the time needed to place each implant. * ISQ will be evaluated at Day 0, 3 weeks, 6 weeks, 3 months, 4 months, and 6 months after implant placement. * Periapical radiographs will be performed at implant placement, loading. and 1, 3, and 5 years after loading to assess marginal bone stability. * Buccal bone height and lingual and buccal bone thickness will be recorded post-intervention, at the time of functional loading, and at 12, 36, and 60 months after loading with CBCT. * Digital impressions will be taken post-operatively, at loading and at 12 months after loading to monitor gingival profile.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Bone Consumption | The surgery will be done using a bone consumption protocol |
| PROCEDURE | Bone expansion | implants will be placed after a bone expansion protocol |
Timeline
- Start date
- 2021-06-03
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2023-12-21
- Last updated
- 2023-12-21
Locations
1 site across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT06178536. Inclusion in this directory is not an endorsement.